The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

R. Crocchiolo, L. Castagna, S. Furst, R. Devillier, B. Sarina, S. Bramanti, J. El-Cheikh, A. Granata, S. Harbi, L. Morabito, C. Faucher, A. Rimondo, D. Girardi, B. Mohty, B. Calmels, C. Carlo-Stella, C. Chabannon, R. Bouabdallah, A. Santoro, N. VeyP. J. Weiller, D. Blaise

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalBone Marrow Transplantation
Publication statusAccepted/In press - Mar 21 2016

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this